Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis?
Spasticity: pathophysiology, evaluation and management.
Kinin-mediated inflammation in neurodegenerative disorders.
The Alice in Wonderland syndrome: an unusual in acute disseminated encephalomyelitis.
Journal Club: Intrathecal effects of daclizumab treatment of multiple sclerosis.
Interleukin-17- and interleukin-22-secreting myelin-specific CD4(+) T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients.
A rare case of mixed connective tissue disease complicated with neuromyelitis optica.
Citrullination of Histone H3 Interferes with HP1-Mediated Transcriptional Repression.
Cognitive rehabilitation of working memory in juvenile multiple sclerosis-effects on cognitive functioning, functional MRI and network related connectivity.
Self-reported Depression and Physical Activity in Adults with Mobility Impairments.
Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions.
Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use.
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain].
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.
Type 1 immune response in progressive multiple sclerosis.
Correction: quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia
A combination trial of estriol plus glatiramer acetate in relapsing-remitting multiple sclerosis: effect on disabilities
Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis.
Efficient transdifferentiation of human adipose-derived stem cells into Schwann-like cells: A promise for treatment of demyelinating diseases.
ACUTE RETINAL NECROSIS AND IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN A NATALIZUMAB-TREATED PATIENT WITH MULTIPLE SCLEROSIS.
Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.
Treatment of resistant rheumatoid arthritis with minocycline: an open study.
Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled study.
The origins of multiple sclerosis: a synthesis
Pages
« first
‹ previous
…
178
179
180
181
182
183
184
185
186
…
next ›
last »